RE002 T Cell Injection for the Treatment of KRAS G12D Mutated Solid Tumors
RE002 T Cell Injection for the Treatment of KRAS G12D Mutated Solid Tumors
Recruiting · NCT06546150 · Registry updated 2025-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RE002 T Cell Injection for the Treatment of KRAS G12D Mutated Solid Tumors | KRAS G12D; T Cell Therapy | Recruiting | Phase 1 | 2025-12-16 | NCT06546150 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Henan Cancer Hospital | 147 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Henan Cancer Hospital | Zhengzhou | China | 67 |